Toll-like receptor-mediated NF-kappaB activation: a phylogenetically conserved paradigm in innate immunity
G. Zhang, and S. Ghosh Toll-like receptor-mediated NF-kappaB activation: a phylogenetically conserved paradigm in innate immunity J. Clin. Invest. 107 2001 13 19
Crystal structure of p50/p65 heterodimer of transcription factor NF-kappaB bound to DNA
F.E. Chen, D.-B. Huang, Y.-Q. Chen, and et al. Crystal structure of p50/p65 heterodimer of transcription factor NF-kappaB bound to DNA Nature 391 1998 410 413
Degradation of promoter-bound p65/RelA is essential for the prompt termination of the nuclear factor kappaB response
S. Saccani, I. Marazzi, A.A. Beg, and et al. Degradation of promoter-bound p65/RelA is essential for the prompt termination of the nuclear factor kappaB response J. Exp. Med. 200 2004 107 113
Intranasal delivery of the cytoplasmic domain of CTLA-4 using a novel protein transduction domain prevents allergic inflammation
J.-M. Choi, M.-H. Ahn, W.-J. Chae, and et al. Intranasal delivery of the cytoplasmic domain of CTLA-4 using a novel protein transduction domain prevents allergic inflammation Nat. Med. 12 2006 574 579
RORγt-specific transcriptional interactomic inhibition suppresses autoimmunity associated with TH17 cells
T.-Y. Park, S.-D. Park, J.-Y. Cho, and et al. RORγt-specific transcriptional interactomic inhibition suppresses autoimmunity associated with TH17 cells Proc. Natl. Acad. Sci. U. S. A. 111 2014 18673 18678
Low-dose FK506 blocks collar-induced atherosclerotic plaque development and stabilizes plaques in ApoE-/- mice
M.M. Donners, I. Bot, L.J. De Windt, and et al. Low-dose FK506 blocks collar-induced atherosclerotic plaque development and stabilizes plaques in ApoE-/- mice Am. J. Transpl. 5 2005 1204 1215